IMMUSOFT CORP

IMMUSOFT CORP is a biotech company in Seattle, United States, founded in 2018. It has raised $29.3M across 5 rounds, most recently a $467K Grant in September 2020.

Immusoft

Employees
1–10
Founded
2018
Total Funding
$29.3M
Last Round
$467K GrantSep 2020
Rounds
5

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 5 funding rounds and 6 investors for this company. The full record is or through the API.

About

Immusoft engineers B cells to function as biological factories for therapeutic protein delivery to patients. Its approach involves programming cells and infusing them back into the patient, where they produce therapeutic proteins over extended periods, using engineered cells as a means of delivering protein therapies.

Summary

It lists 1–10 employees. It has raised $29.3M in total across 5 rounds, most recently a $467K Grant round in Sep 2020. Investors include 600 Mile Challenge Fund, FF Science and Breakout Ventures.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
GrantSBIR Phase I (NIH)Sep 2020
$467K

Sign up to see all 5 events

Funding: Seed through Grant. Amounts, valuations, and investors where available.

Investors

Similar Companies

Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

IMMUSOFT CORP on Indexed.vc
<a href="https://indexed.vc/companies/immusoft-corp"><img src="https://indexed.vc/api/badge/company/immusoft-corp" alt="IMMUSOFT CORP on Indexed.vc" width="260" height="76" /></a>